静脉支架市场规模、份额和成长分析（按技术、产品、植入方法、材质、支架设计、支架植入部位和地区划分）－2026-2033年产业预测

预计到 2024 年，全球静脉支架市场规模将达到 109.8 亿美元，到 2025 年将达到 116 亿美元，到 2033 年将达到 179.3 亿美元，预测期（2026-2033 年）的复合年增长率为 5.6%。

由于静脉疾病盛行率不断上升和人口老化，全球静脉支架市场正经历强劲增长。越来越多的患者寻求有效治疗慢性静脉功能不全和深层静脉栓塞症等疾病，推动了对支架治疗解决方案的需求。支架技术的进步，包括创新设计和材料的运用，有助于改善临床疗效，进一步促进市场成长。此外，患者和医疗专业人员对静脉疾病的认识不断提高，也显着推动了全球静脉支架市场的整体扩张，预示着未来发展和市场动态的良好前景。

全球静脉支架市场驱动因素

由于慢性静脉疾病（包括血栓后症候群和深层静脉栓塞症）的盛行率不断上升，全球静脉支架市场正经历显着成长。这些疾病通常需要介入治疗来恢復血流并减轻长期併发症。此外，诊断能力的提高以及老龄化社会对血管健康的日益重视，正在推动已开发国家和开发中国家医疗保健市场对静脉支架的需求。随着越来越多的患者寻求有效的静脉疾病治疗方法，对患者照护和创新医疗解决方案的日益重视预计将推动该行业的持续扩张。

限制全球静脉支架市场的因素

全球静脉支架市场面临许多限制因素，其中高成本主要体现在器材本身、术前影像检查和专业服务等。这些费用可能会限制病患的就医机会，尤其是在健保报销体係不完善的地区。此外，这种经济负担往往也阻碍了诊所和医院采用先进的支架技术。在价格敏感型市场和公共医疗体系中，如果没有扩大保险覆盖范围和提高营运效率，就难以实现支架技术的广泛应用。这些因素共同阻碍了支架技术的普及，并限制了市场的整体成长潜力。

全球静脉支架市场趋势

全球静脉支架市场正经历着向微创治疗方案的显着转变，其驱动力在于缩短恢復时间、降低手术风险并提高病患满意度。随着医疗系统优先考虑门诊和当日手术方案，对相容这些创新技术的静脉支架的需求日益增长，尤其是在髂股静脉阻塞等病例中。这种转变正在影响医院的采购模式，并促使製造商重新设计产品以适应不断变化的静脉治疗格局，最终改善全球医疗机构的治疗效果和病患体验。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球静脉支架市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 药物释放型支架
• 裸金属支架
• 覆膜支架
• 生物可吸收支架

全球静脉支架市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 冠状动脉支架
• 外周支架
  • 颈动脉支架
  • 股动脉支架
  • 肾动脉支架
  • 髂动脉支架
  • 其他外周支架
• EVAR血管支架
  • 腹部主动脉血管瘤血管支架
  • 胸主动脉瘤血管支架

全球静脉支架市场规模（以植入方式划分）及复合年增长率（2026-2033 年）

• 球囊扩张型支架
• 自动扩张型支架

全球静脉支架市场规模（按材质和复合年增长率划分）（2026-2033 年）

• 金属材料
  • 钴铬
  • 铂金铬
  • 镍钛
  • 不銹钢
• 聚合物材料
  • 可生物降解聚合物
  • 不可生物降解聚合物

全球静脉支架市场规模（依支架类型划分）及复合年增长率（2026-2033 年）

• 编织
• 雷射切割
• 开放式细胞
• 封闭式

全球静脉支架市场规模（依支架植入部位划分）及复合年增长率（2026-2033 年）

• 下肢
• 胸部
• 腹部
• 上肢

全球静脉支架市场规模（按适应症和复合年增长率划分）（2026-2033 年）

• 慢性深层静脉栓塞症
• 血栓后症候群
• 梅-瑟纳症候群
• 胡桃钳综合症
• 血液透析/动静脉瘻管
• 其他的

全球静脉支架市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心
• 专业医疗中心
• 其他的

全球静脉支架市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Boston Scientific Corporation（United States）
• Cook Medical（United States）
• BD（Becton, Dickinson and Company）（United States）
• Bard Peripheral Vascular Inc.（United States）
• Veniti Inc.（United States）
• Medinol Ltd.（Israel）
• Natec Medical Ltd.（Mauritius）
• Optimed Medizinische Instrumente GmbH（Germany）
• Bentley InnoMed GmbH（Germany）
• iVascular SLU（Spain）
• DISA Vascular（South Africa）
• Relisys Medical Devices Ltd.（India）
• Biotronik SE & Co. KG（Germany）
• Alvimedica Medical Technologies（Turkey）
• Cordis, Cardinal Health（United States）
• Sahajanand Medical Technologies Pvt. Ltd.（India）
• P+F Products+Features GmbH（Germany）
• MicroPort Scientific Corporation（China）
• Hexacath（France）

结论与建议

Global Venous Stents Market size was valued at USD 10.98 Billion in 2024 and is poised to grow from USD 11.6 Billion in 2025 to USD 17.93 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026-2033).

The global venous stents market is experiencing robust growth, fueled by a rise in venous disease prevalence and an expanding aging population. With a growing number of patients seeking efficient treatment for conditions like chronic venous insufficiency and deep vein thrombosis, the demand for stenting solutions is on the rise. Advances in stent technology, including innovative designs and materials, are contributing to improved clinical outcomes, further bolstering market growth. Additionally, heightened awareness among patients and healthcare providers regarding venous diseases is significantly enhancing the overall expansion of the global venous stents sector, indicating a promising outlook for future developments and market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Venous Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Venous Stents Market Segments Analysis

Global Venous Stents Market is segmented by Technology, Product, Mode Of Delivery, Material, Stent Design, Placement of Stent, Indication, End-user and region. Based on Technology, the market is segmented into Drug-Eluting Stents, Bare Metal Stents, Covered Stents and Bioabsorbable Stents. Based on Product, the market is segmented into Coronary Stents, Peripheral Stents and Evar Stent Grafts. Based on Mode Of Delivery, the market is segmented into Balloon-Expandable Stents and Self-Expanding Stents. Based on Material, the market is segmented into Metallic Materials and Polymeric Materials. Based on Stent Design, the market is segmented into Braided, Laser-cut, Open-cell and Closed-cell. Based on Placement of Stent, the market is segmented into Lower Limbs, Thorax, Abdomen and Upper Limbs. Based on Indication, the market is segmented into Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Nutcracker Syndrome, Hemodialysis / Arteriovenous Fistulae and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Venous Stents Market

The global venous stents market is experiencing significant growth due to the rising prevalence of chronic venous conditions, including post-thrombotic syndrome and deep vein thrombosis. These conditions often necessitate interventional therapies aimed at restoring blood flow and mitigating long-term complications. Additionally, there is growing demand for venous stents across both established and developing healthcare markets, driven by improved diagnostic capabilities and heightened awareness of vascular health among aging populations. As more individuals seek effective treatment options for venous disorders, the industry is poised for continuous expansion, reflecting an increased focus on patient care and innovative medical solutions.

Restraints in the Global Venous Stents Market

The Global Venous Stents market faces significant restraints primarily due to the high costs associated with devices, pre-procedure imaging, and specialized services. These expenses can limit patient access, especially in areas where reimbursement systems are underdeveloped. Furthermore, the financial burden often discourages clinics and hospitals from adopting advanced stent technologies. In price-sensitive markets and public healthcare systems, achieving penetration can prove difficult unless there is an improvement in insurance coverage and operational efficiencies. These factors collectively hinder broader adoption and limit the market's overall growth potential.

Market Trends of the Global Venous Stents Market

The Global Venous Stents market is experiencing a significant trend towards less invasive treatment options, driven by a pursuit of shorter recovery times, reduced operational risks, and enhanced patient satisfaction. As healthcare systems increasingly prioritize outpatient care and day surgery initiatives, there is a rising demand for venous stents that are compatible with these innovative techniques, particularly for conditions such as iliofemoral vein obstruction. This shift is influencing hospital purchasing patterns and inspiring manufacturers to redesign products to align with the evolving landscape of venous interventions, ultimately aiming to improve treatment outcomes and patient experiences across health settings worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Venous Stents Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Drug-Eluting Stents
• Bare Metal Stents
• Covered Stents
• Bioabsorbable Stents

Global Venous Stents Market Size by Product & CAGR (2026-2033)

• Market Overview
• Coronary Stents
• Peripheral Stents
  • Carotid Artery Stents
  • Femoral Artery Stents
  • Renal Artery Stents
  • Iliac Artery Stents
  • Other Peripheral Stents
• Evar Stent Grafts
  • Abdominal Aortic Aneurysm Stent Grafts
  • Thoracic Aortic Aneurysm Stent Grafts

Global Venous Stents Market Size by Mode Of Delivery & CAGR (2026-2033)

• Market Overview
• Balloon-Expandable Stents
• Self-Expanding Stents

Global Venous Stents Market Size by Material & CAGR (2026-2033)

• Market Overview
• Metallic Materials
  • Cobalt Chromium
  • Platinum Chromium
  • Nickel Titanium
  • Stainless Steel
• Polymeric Materials
  • Biodegradable Polymers
  • Non-Biodegradable Polymers

Global Venous Stents Market Size by Stent Design & CAGR (2026-2033)

• Market Overview
• Braided
• Laser-cut
• Open-cell
• Closed-cell

Global Venous Stents Market Size by Placement of Stent & CAGR (2026-2033)

• Market Overview
• Lower Limbs
• Thorax
• Abdomen
• Upper Limbs

Global Venous Stents Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Chronic Deep Vein Thrombosis
• Post Thrombotic Syndrome
• May-Thurner Syndrome
• Nutcracker Syndrome
• Hemodialysis / Arteriovenous Fistulae
• Others

Global Venous Stents Market Size by End-user & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Centers
• Others

Global Venous Stents Market Size & CAGR (2026-2033)

• North America (Technology, Product, Mode Of Delivery, Material, Stent Design, Placement of Stent, Indication, End-user)
  • US
  • Canada
• Europe (Technology, Product, Mode Of Delivery, Material, Stent Design, Placement of Stent, Indication, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Mode Of Delivery, Material, Stent Design, Placement of Stent, Indication, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Mode Of Delivery, Material, Stent Design, Placement of Stent, Indication, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Mode Of Delivery, Material, Stent Design, Placement of Stent, Indication, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bard Peripheral Vascular Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veniti Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medinol Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natec Medical Ltd. (Mauritius)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optimed Medizinische Instrumente GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bentley InnoMed GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iVascular S.L.U. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DISA Vascular (South Africa)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Relisys Medical Devices Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvimedica Medical Technologies (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis, Cardinal Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sahajanand Medical Technologies Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• P+F Products + Features GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hexacath (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations